The anticancer efficacy of miRNA/ATE-APT was superior to those of other treatments in vivo.243 This PSMA-targeted system may prove useful in widening the therapeutic window and allow for selective killing of PCa cells in bone metastasis. Here, FOLH1 is linked to posterior cortical atrophy.